Chromatin states define tumour-specific T cell dysfunction and reprogramming

Philip, Mary, Fairchild, Lauren, Sun, Liping, Horste, Ellen L., Camara, Steven, Shakiba, Mojdeh, Scott, Andrew C., Viale, Agnes, Lauer, Peter, Merghoub, Taha, Hellmann, Matthew D., Wolchok, Jedd D., Leslie, Christina S., Schietinger, Andrea·2017·Nature
DOI 10.1038/nature22367

Cited by (934)

Items 901–934 of 934

  1. Mapping the immune landscape in small cell lung cancer unveils a distinct tumor-reactive CD8+ T cell molecular signature
    Krutika Khinvasara, Elif Diken, Jennifer V. Gerbracht, Enes Huduti, Joshua D’Rozario, Tana Omokoko, Sebastian Newrzela, Özlem Akilli‐Öztürk, Franziska Lang, Barbara Schrörs et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  2. Targeting DNMT1 augments anti-tumor CD8⁺ T cell function
    Maya G. Deshmukh, Danielle K. Sohai, Kamal Obbad, Koonam Park, Simon Milette, Peili Gu, Henna S. Nam, Andrew J. Daniels, Krasimir A. Spasov, Michael E. Hurwitz et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  3. From exhaustion to functional cure: frontiers in reversing HBV-specific T-cell immunity
    Lifen Liang, Xiangping Xie, Shuangyan He, Zhou L, Yehong Yue · 2026 · Frontiers in Immunology
  4. Artificial Intelligence for Identifying Tumor‐Reactive CD8 + T Cells: Biological Principles, Computational Advances, and Future Directions
    Chao Yang, Yingying Sun, Yan Zhang, Yifen Shi, Zhiwen Shi · 2026 · Med Research
  5. Rewriting CAR-T cell fate: CRISPR/Cas gene editing for solid tumor therapy
    Wenjing Liu, Jiayi Gu, Chenghao Xie, Du Bing, Mingyao Liu, Jiqin Zhang · 2026 · Frontiers in Immunology
  6. Targeting the fate of exhausted CD8+ T cells
    Daniel T. Utzschneider, Stephen T. Turner · 2026 · Trends in Immunology
  7. Translational repression of 5’ TOP mRNAs in chronically activated CD8+ T cells in vitro
    Erica S. Pledger, Navya Ambavaram, Lucas Ferguson, Jamie H. D. Cate · 2026 · RNA Biology
  8. Short-chain fatty acids act as metabolic and epigenetic regulators in CAR T cell therapy
    Mingyang Ma, Chen-Xin Zhou, Xinyu Shi, Jian-Min Zhu, Cai‐Wen Duan · 2026 · Molecular Therapy Oncology
  9. Proteomics of human cancer-associated T cells identifies regulators of T cell functionality
    Kaspar Bresser, Žan Hozjan, Nila H. Servaas, Suzan Stelloo, Cornelia G. Spruijt, Maia Nestor Martin, Aurélie Guislain, Nandhini Kanagasabesan, Stijn F.K. Kneefel, Arie Johan Hoogendijk et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Cancer Immunotherapy: Therapeutic Limitations and Next-Generation Precision Strategies
    Dayeon Ko, Subin Park, Kyung-Ho Nam, Je‐Min Choi, Kyung‐min Lee · 2026 · Immune Network
  11. Decoding T cell exhaustion in the tumour microenvironment
    Jin A Park, Jeyeon Im, Sung-Min Hwang · 2026 · Experimental & Molecular Medicine
  12. Recent advances in molecular mechanisms to improve the efficacy of CAR-T cell therapy for viral diseases, cancer, and autoimmune diseases
    Hany E. S. Marei, Giacomo Pozzoli, Sara Caratelli, Carlo Cenciarelli · 2026 · Stem Cell Research & Therapy
  13. Neuroregulation as a modulatory force in immune checkpoint inhibitor resistance: mechanistic neuro-immune crosstalk informing biomarker-led diagnosis and targetable therapeutic sensitization
    Mingze Ma, Gaoyong Hu, Yuankai Hao, Haiyang Yu, Ruiyu Mou, Yingjie Jia · 2026 · Pharmacology & Therapeutics
  14. Simulated Annealing Identifies Five Shared Drivers of T Cell Exhaustion Across Four Human Cancers
    alireza ebadi, Maryam Hashemi · 2026 · medRxiv
  15. The inflammation–epigenetics axis in gastric cancer: Helicobacter-driven field defects, immune escape, and therapeutic frontiers
    Yue Bai, Zhongran Lu · 2026 · Frontiers in Immunology
  16. STK11 deficiency drives NSCLC immune resistance via ETNK2-mediated phosphoethanolamine accumulation
    Wei Zhang, Jing Hu, Zhengbin Zhang · 2026 · International Immunology
  17. Immune remodeling of tumor-draining lymph nodes: mechanistic determinants of checkpoint blockade responsiveness
    Caiyan Jia, Shuxuan Li, Muhua Chen, Wuxia Yang, Yanqi Song, Aidi Wang, Baoshan Liu · 2026 · Frontiers in Immunology
  18. In vivo CAR-T cell generation: a production-rate framework linking vector and cellular pharmacology
    Jing Hu, Dandan Zhu, Shanliang Zheng · 2026 · Frontiers in Immunology
  19. Why CD4+ T cells matter in adoptive cell therapy for solid cancers
    S. Jegatheeson, Christina M. Scheffler, M. De Bondt, PK Darcy, Paul Joseph Neeson · 2026 · Immuno-Oncology Technology
  20. Targeting ZMYND8 unleashes IL-2 signalling to override T cell exhaustion
    Yan Wang, Hao Shi, Nicole M. Chapman, Anil KC, Renqiang Sun, Hao Song, Xiaoxi Meng, Xiang Sun, Hongbo Chi · 2026 · Nature
  21. SPRED2 Negatively Regulates CD8 + T Cell‐Mediated Antitumor Immunity in Breast Cancer
    Miao Tian, Teizo Yoshimura, Kun Zhao, Chunning Li, Tong Gao, Ziyi Wang, Masayoshi Fujisawa, Toshiaki Ohara, Akihiro Matsukawa · 2026 · Advanced Science
  22. HDACs-targeting photosensitizer-based local-therapy augmenting photoimmunotherapy in bladder cancer
    Yuanming Chen, Yang Yu, Wentao Xu, Lian‐Feng Fan, Qiyu Chen, Salvatore Federico, Minjia Wang, Tianming Cheng, Leilei Shi, Bangmin Han et al. · 2026 · Materials Today Advances
  23. From failure to fate: Pressure-driven exhaustion in solid-tumor CAR T-cell therapy
    Pei Wang, Yuehong Zhou, Yuan Wang, Yan Li, Xue Xiao, Chenhui Wang · 2026 · Cell Insight
  24. Cytokine-mediated activation of exhausted T cells
    Eva Goljat, Rahel Daetwyler, Nima Yassini, Nikolas Rakebrandt, Zhaorong Li, Francisco Javier Quintana, Nicole Joller · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  25. Why only 3 months? Immunological constraints on CAR-T therapy in gastrointestinal cancers
    Liping Zeng, Sheng Wei, Nan Chen, Xiangping Xie · 2026 · Frontiers in Immunology
  26. Chemokines as regulators of CAR-T cell trafficking, function, and context-dependent tumor cell death
    Ksenia Levchuk, Alexey Petukhov, Shynggys Tursymbek, Kuanysh Seitkamal, Arailym Bertleuova, Denis Bulanin, Nikolai A. Barlev · 2026 · Frontiers in Immunology
  27. CD39 on CD8 + Tumour‐Infiltrating Lymphocytes: A Paradoxical Marker of Tumour Reactivity and Immunosuppression
    Manolo Sambucci, Daniela Fenoglio, Francesca Ferrera, Laura Camporesi, Andrea Lagazio, Giovanna Borsellino, Luca Battistini, Gilberto Filaci · 2026 · European Journal of Immunology
  28. Mapping Immune Exhaustion Markers in CD8⁺ T Cells within Syngeneic Tumor Microenvironments
    Virginie Féliu, Marie Michelas, Y lan Blanchard, Lise Scandella, Anna Salvioni, Clara‐Maria Scarlata, Bastien Gerby, Jean‐Pierre Delord, Maha Ayyoub, Christel Devaud · 2026 · Research Square
  29. Opposing NF-κB–associated transcriptional changes accompany high CAR density and signaling rest in CAR-T cells
    Qian Wang, Zhoulin Chen, Haohan Yang, Youcheng Yang, Shubing Wang · 2026 · Research Square
  30. Nanotechnology for next-generation CAR T-Cell manufacturing
    Mark Schvartzman, Saba Ghassemi · 2026 · Frontiers in Immunology
  31. Beyond Exhaustion: The RNA Regulatory Layer of Tissue‐Instructed T Cell Dysfunction
    Francesco Andreata, Federica Marasca, Beatrice Bodega, Matteo Iannacone · 2026 · European Journal of Immunology
  32. Dataset related to article "Lymph-node-derived stem-like but not tumor-tissue-resident CD8+ T cells fuel anticancer immunity"
    Sharanya K M Wijesinghe, Lisa Rausch, Sarah S. Gabriel, Giovanni Galletti, Marco De Luca, Lei Qin, Lifen Wen, Carlson Tsui, Kevin Man, Leonie Heyden et al. · 2024 · Zenodo (CERN European Organization for Nuclear Research)
  33. From dysfunction to differentiation: a new paradigm of T cell exhaustion
    V. M. Stepanova, A. Logvinov, E. A. Emelyanov, N. A. Katin, Yury P. Rubtsov · 2026 · Acta Naturae
  34. Palmitate drives an epigenetic dead end in CD8 T cells
    Johannes Schroth, Siân M. Henson · 2026 · Immunometabolism